The Unspoken Truth About Prostate Cancer: Duke's Revolutionary Therapies

Skip to main content.In recent years, clinicians have begun treating patients with late-stage, therapy resistant prostatecancers using a monthly, high-dose injection of testosterone in a technique called bi-polar androgen therapy, or BAT. Prostatecancer awareness campaigns exploit this fear, pushing men into unnecessary biopsies, surgeries, radiation, and hormone therapy—despite no survival advantage and a very high cost in sexual and urinary health. Collateral Damage: Suffering Wives and Partners. Prostatecancer is the second most common cause of cancer-related deaths in men. “These findings suggest that patients with gene fusion could benefit from combination therapy,” says Yarden. “They also highlight the need for caution when prescribing steroids, since these drugs may... The 76 year-old Israeli leader said he underwent the initial surgery for an enlarged benign prostate in 2024 and has been under routine medical monitoring. "A tiny spot of less than a centimetre" was discovered during the most recent check up. Don't be afraid to ask questions aboutprostatecancer, no matter how minor they may seem.Why or why not? If I’m choosing to be treated, are both surgery and radiation therapy options for me? What are the pros and cons of each? What types of radiation therapy might work best for me? Stay informed on 2026 ProstateCancer Guidelines from EAU. The ProstateCancer (PCa) Guidelines Panel have prepared this guidelines document to assist medical professionals in the evidence-based management of PCa. The truth is, many common solutions fail because they don't tackle the complex, multi-faceted nature of prostate health.

The Unspoken Truth About Prostate Cancer: Duke's Revolutionary Therapies 1